Figure 2
Overall survival in univariate analyses of patient subgroups. Patient subgroups were defined by baseline demographic and disease characteristics. The dotted line represents the overall unstratified HR for azacitidine vs CCR.
Overall survival in univariate analyses of patient subgroups. Patient subgroups were defined by baseline demographic and disease characteristics. The dotted line represents the overall unstratified HR for azacitidine vs CCR.
